534 results on '"Swift, Robert M."'
Search Results
2. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder
3. Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness
4. Altered sleep architecture following consecutive nights of presleep alcohol.
5. Commentary on Efficacy and Safety of Low dose ondansetron as a prospective precision medicine to treat alcohol use disorder phenotypes
6. A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers
7. Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin
8. Noradrenergic targets for the treatment of alcohol use disorder
9. Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial
10. Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial
11. Mifepristone as a pharmacological intervention for stress‐induced alcohol craving: A human laboratory study.
12. Contingent Vouchers and Motivational Interviewing for Cigarette Smokers in Residential Substance Abuse Treatment
13. Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults
14. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: Exploratory findings
15. Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment
16. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms
17. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers
18. Separate and Combined Effects of Very Low Nicotine Cigarettes and Nicotine Replacement in Smokers with Schizophrenia and Controls
19. Pharmacotherapy of Substance Use, Craving, and Acute Abstinence Syndromes
20. Pharmacotherapy of Alcohol and Drug Dependence
21. A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers
22. Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls
23. In Vitro and In Vivo Release of Naltrexone from Two Types of Poly(lactide-co-glycolide) Matrices
24. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder
25. Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder
26. Subjective and physiological responses to smoking cues in smokers with schizophrenia
27. Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial
28. Biobehavioral mechanisms of topiramateʼs effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments
29. Pharmacotherapy of Substance Use, Craving, and Acute Abstinence Syndromes
30. Assessment of Ethanol Consumption with a Wearable, Electronic Ethanol Sensor/Recorder
31. Intolerance for Smoking Abstinence Questionnaire: Psychometric properties and relationship to tobacco dependence and abstinence
32. Naltrexone treatment for alcoholics: Effect on cigarette smoking rates
33. Effects of Idazoxan on Alcohol Pharmacokinetics and Intoxication: A Preliminary Human Laboratory Study
34. Relationship Between the Thyroid Axis and Alcohol Craving
35. Morphine and Endorphins Modulate Dopamine Turnover in Rat Median Eminence
36. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial
37. Translating the Semi-Structured Assessment for Drug Dependence and Alcoholism in the Western Pacific: Rationale, Study Design and Reliability of Alcohol Dependence
38. The Relationship of Appetitive, Reproductive and Posterior Pituitary Hormones to Alcoholism and Craving in Humans
39. Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic
40. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
41. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study
42. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
43. Polymorphisms of the [mu]-opioid receptor and dopamine [D.sub.4] receptor genes and subjective responses to alcohol in the natural environment
44. Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders
45. Pharmacotherapy for alcoholic patients with alcoholic liver disease
46. Ondansetron Reduces Naturalistic Drinking in Nontreatment-Seeking Alcohol-Dependent Individuals with the LL 5′-HTTLPR Genotype: A Laboratory Study
47. Typologies of Alcohol Dependence. From Jellinek to Genetics and Beyond
48. Pharmacotherapy of Dual Substance Abuse and Dependence
49. Topiramate for treating alcohol dependence: a randomized controlled trial
50. Olanzapine attenuates cue-elicited craving for tobacco
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.